(Q45037067)
Statements
Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial (English)
M R Bristow
H Krause-Steinrauf
R Nuzzo
J Lindenfeld
B Hattler
W T Abraham
L Olson
S Krueger
S Thaneemit-Chen
J M Hare
H S Loeb
M J Domanski
E J Eichhorn
R Zelis